MHRA (Medicines and Healthcare products Regulatory Agency) issues POC (point of care) microalbuminuria test devices report:
This article was originally published in Clinica
Point of care devices for the detection and semi-quantitation of microalbuminuria are the subject of the latest POC urine screening device evaluation report to be published by the UK Medicines and Healthcare products Regulatory Agency (MHRA). The report includes technical and user assessments of analytical performance, suitability for point of care and reliability. The devices evaluated are: Bayer Microalbumin read of the Bayer Clinitek Status urine strip reader, Bayer Microalbustix, Roche Diagnostics' [Chemstrip] Micral test and Diagnostic Chemicals' ImmunoDip urinary albumin.